Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Richard C Duke

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Duke, Richard

Item TypeName
Academic Article A role for CD95 ligand in preventing graft rejection.
Academic Article Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage.
Academic Article Adenoviral-mediated gene transfer in lymphocytes.
Academic Article Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.
Academic Article Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.
Academic Article Transplantation of cells and tissues expressing Fas ligand.
Academic Article NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type.
Academic Article Apoptosis and CD95 ligand in immune privileged sites.
Academic Article Murine heart transgenic Fas ligand expression protects against allograft rejection.
Academic Article Enhancing antimelanoma immune responses through apoptosis.
Academic Article Methods of analyzing chromatin changes accompanying apoptosis of target cells in killer cell assays.
Academic Article Proinflammatory consequences of transgenic fas ligand expression in the heart.
Academic Article Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
Academic Article Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis.
Academic Article Regulation of Fas-mediated apoptosis by N-ras in melanoma.
Academic Article Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer.
Concept Fas Ligand Protein
Grant FAS LIGAND AS AN IMMUNOSUPPRESSIVE AGENT
Grant FAS LIGAND AS AN IMMUNOSUPPRESSIVE AGENT
Grant CD95 (FAS) LIGAND AND IMMUNE PRIVILEGED TISSUE

Search Criteria
  • Fas Ligand Protein

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)